Europe Insulin Pumps Market Forecast by 2033
Market Size in 2024: USD 1,409.6 Million
Market Forecast in 2033: USD 2,168.1 Million
Market Growth Rate 2025-2033: 4.90%
The Europe insulin pumps market reached USD 1,409.6 Million in 2024 and is projected to grow steadily, reaching USD 2,168.1 Million by 2033. This reflects a compound annual growth rate of 4.90% between 2025 and 2033, driven by rising diabetes prevalence, technological advancements, and supportive healthcare policies across the region.
Growth Drivers of the European Insulin Pumps Market
Increasing Diabetes Prevalence Across Europe
More people develop diabetes. This development drives insulin pumps’ creation and use. In 2021, about 61 million European adults had diabetes and an increase to 68 million is expected in 2030. Healthcare systems worldwide are investigating advanced diabetes management technologies since type 1 and type 2 diabetes patients are increasing in number. Insulin pumps infuse subcutaneous insulin without stopping. This gives better glycemic control when compared to subcutaneous injection. This growing patient population, coupled along with the need for well-executed chronic disease management, is expected to drive demand for insulin pumps in Europe.
Technological Advancements and Smart Integration
New developments in other medical devices also burnish the future of insulin pumps, the most prominent of which is the increasing collaboration of insulin pumps with continuous glucose monitoring (CGM) devices, allowing real-time monitoring and automated delivery. Other companies have developed Bluetooth-equipped pumps that communicate with the user’s smartphone, allowing insulin levels to be monitored remotely, improving the convenience and accuracy of use and improving the safety of continuous glucose control. Such smart technologies are likely to proliferate as healthcare providers and patients turn to personalized, data-driven approaches to diabetes management.
Government Support and Reimbursement Policies
The adoption of insulin pumps is helped by reimbursement policies incorporated into the healthcare plans of several European governments, as the insulin pump is covered (partially or in full) by the national health insurance systems of many EU nations. The increasing importance of digital health and chronic disease management in the European Union (EU) is expected to increase investments by the vendors in innovative medical devices. Subsidies and funding initiatives are expected to reduce the cost of devices for patients, which in turn is expected to accelerate the adoption rate. The supportive regulations are also increasing the insulin pumps market in Europe.
Request a sample of the full report here:Â https://www.imarcgroup.com/europe-insulin-pumps-market/requestsample
Europe Insulin Pumps Market Segmentation:
Product Type Insights:
- Insulin Pumps
- Tethered Pumps
- Disposable/Patch Insulin Pumps
- Insulin Pumps, Supplies, and Accessories
- Infusion Set Insertion Devices
- Insulin Reservoirs/Cartridges
Distribution Channel Insights:
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Diabetes Clinics/Centers
- Others
Country-Wise Insights:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Europe Insulin Pumps Market News
- Medtronic announced advancements in hybrid closed-loop insulin pump systems, enhancing automated insulin delivery for patients in Europe.
- Roche expanded its diabetes care portfolio with new digital health integrations for insulin pumps across European markets.
- Tandem Diabetes Care introduced its t:slim X2 insulin pump with Control-IQ technology in several European countries.
- Ypsomed partnered with Abbott to integrate continuous glucose monitoring with its insulin pump systems for improved patient outcomes.
- European healthcare authorities increased reimbursement coverage for insulin pumps, making them more accessible to patients with type 1 diabetes.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
